Where Patient Education Breaks Down in Breast Cancer Care
When education is incomplete, patients don’t just feel uninformed; they feel dismissed. The post Where Patient Education Breaks Down in Breast Cancer Care appeared first on MedCity News.
When education is incomplete, patients don’t just feel uninformed; they feel dismissed. The post Where Patient Education Breaks Down in Breast Cancer Care appeared first on MedCity News.
[Sponsored] Give us a few minutes of your time for our survey and we’ll make it worth your while! The post How Are Payers and Providers Thinking of AI and Cybersecurity? appeared first on MedCity News.
The latest KFF Tracking Poll on Health Information and Trust finds roughly three in ten adults report turning to social media (31%) or AI chatbots (29%) at least monthly for health information and advice. The top reasons people report turning to social media for health advice are wanting to hear from those with similar experiences…
This page tracks emerging developments in the federal government’s approach to Medicaid program integrity, along with the implications of those actions for different states.
WHITESBURG, Ky. — Drugs and the consequences of addiction are woven into the fabric of Jamie Madden’s life. Her earliest memory is of standing on the passenger seat of her dad’s car as a toddler, wearing a peach-colored blouse, while he drove from their Kentucky home to Florida to pick up drugs. On a stop…
Sen. Ron Wyden and 14 Democratic co-sponsors plan to introduce legislation Thursday to cap consumers’ potential out-of-pocket costs in traditional Medicare, resurfacing a long-running debate over why the program doesn’t limit beneficiary spending. Even the bill’s backers say securing passage this year is a long shot. But the effort is one more opportunity for Democrats…
By MICHAEL MILLENSON It took 129 years for the inalienable rights proclaimed in America’s Declaration of Independence to apply to the rights of patients in relationship to their doctors. In 1905, an Illinois appellate court ruled in favor of a woman who’d sued her surgeon for performing a hysterectomy without disclosing in advance what procedure…
Gilead Sciences antibody drug conjugate Trodelvy is now approved as a first-line treatment for triple-negative breast cancer. This expanded approval for Trodelvy comes with a slightly broader label that gives it an edge over the AstraZeneca and Daiichi Sankyo ADC Datroway. The post New FDA Nod Keeps Gilead Drug Competitive With AstraZeneca & Daiichi in…
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers. The post New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases appeared first on MedCity News.
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News.